Latest Media Releases

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

SomnoMed Limited, Appendix 4C (ASX:SOM)

Quarterly report for entities admitted on the basis of commitments For further information please download PDF attached:

SomnoMed Records 30% Growth in Direct Sales Revenues of Somnodent Devices in First Half of 2015/16 (ASX:SOM)

19th January 2016, SomnoMed Limited (ASX:SOM) announced total revenues generated from the sale of SomnoDent® devices for the first six months of the financial year 2015/16 increased by 30.3%, c...read more

SomnoMed Recognised as Obstructive Sleep Apnea Company of the Year at the Annual Australian Excellence Awards (ASX:SOM)

Sydney, Australia 10th December 2015, SomnoMed Limited (ASX:SOM) was recently recognised and honoured by Frost & Sullivan in their awards for 2015 by receiving Obstructive Sleep Apnea Company o...read more

SomnoMed Announces Acquisition of Strong Dental, Canada (ASX:SOM)

3rd November 2015, SomnoMed Limited (SOM:ASX) announced today that its subsidiary SomnoMed Canada Inc. acquired the business of Strong Dental (“SD”) in Leamington, Ontario, Canada for a...read more

SomnoMed Announces 250,000 Patients Exceeded (ASX:SOM)

22nd October 2015, SomnoMed Limited (ASX:SOM) is proud to announce that it passed the milestone of having fitted over one quarter of a million patients with SomnoDent® devices since its incepti...read more

SomnoMed Announces Growth Acceleration in the US Leads to New Record Quarter (ASX:SOM)

13th October 2015, SomnoMed Limited (ASX:SOM) announced that an outstanding growth performance in US direct sales in Q1, 37.8% above the same quarter in the previous year and a new record of 6,888 ...read more

SomnoMed 2015 Annual Report (ASX:SOM)

BUSINESS OVERVIEW The financial year 2014/15 finished with total sales of 51,355 MAS units, 18.2% higher than in the previous year. The year finished on a positive note with growth o...read more

SomnoMed Preliminary Final Report - 30 June 2015 (ASX:SOM)

Review of the financial year 2015 ?The financial year 2014/15 finished with total sales of 51,355 MAS units, 18.2% higher than in the previous year. The year finished on a positive n...read more

SomnoMed Investor Presentation, Financial Year 2014-15 (ASX:SOM)

- Continuous growth in volume and revenues - Broadening product line, geographic coverage and medical initiatives led to an accelerated growth in last two years ...read more

SomnoMed Receives FDA 510(k) Approval for SomnoDent Devices with Wearable Complicance Micro-Recording (ASX:SOM)

22nd June 2015, SomnoMed Limited (SOM:ASX) announced today that it had received FDA approval to commercialize their wearable SomnoDent devices fitted with DentiTrac® Micro-Recorders. SomnoMed i...read more

SomnoMed to Acquire 100% of SMH Biomaterial AG (ASX:SOM)

25th May 2015, SomnoMed Limited (SOM:ASX) SomnoMed announced today that it has reached agreement with its co-shareholder in SMH Biomaterial AG, Mr. Konrad Hofmann, to acquire his 50% holding in the...read more

Somnomed Limited, Appendix 4D and Half-Year Financial Report (ASX:SOM)

This half-year report is for the six months ended 31 December 2014. The previous corresponding period is the half-year ended 31 December 2013. The information in this report should b...read more

Somnomed Limited, Investor Presentation (ASX:SOM)

Global highlights of the first half financial year 2014/15 - Strong growth in volume and revenues - First half profitable after significant expansion of op...read more

Somnomed Limited, Appendix 4C Quarterly Report (ASX:SOM)

Quarterly report for entities admitted on the basis of commitments Consolidated statement of cash flows For further information please download PDF attached...read more

Somnomed Limited, Growth Targets Achieved (ASX:SOM)

28th January 2015, SomnoMed Limited (SOM:ASX) is pleased to announce Q2 sales of 13,575 units, which set a new quarterly record and brought the first half volume to a total of 24,775 units, in line...read more

Viewing: 31 - 45 of 58 Previous | Next